Mr Edward Morris, RN, BSN, CRNFA | |
424 Savannah Rd, Lewes, DE 19958-1462 | |
(302) 645-3316 | |
Not Available |
Full Name | Mr Edward Morris |
---|---|
Gender | Male |
Speciality | Registered Nurse |
Location | 424 Savannah Rd, Lewes, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003204645 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | L1-0015371 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Edward Morris, RN, BSN, CRNFA 9 E Thrush Dr, Milford, DE 19963-3921 Ph: (302) 424-1846 | Mr Edward Morris, RN, BSN, CRNFA 424 Savannah Rd, Lewes, DE 19958-1462 Ph: (302) 645-3316 |
News Archive
Millions of students across the country soon will share more than their "two cents" as they collect spare change to benefit The Leukemia & Lymphoma Society's (LLS) School & Youth campaign during Olive Garden's 16th-annual Pasta for Pennies program.
Radiometer is proud to be a gold sponsor of this year's European Congress on Emergency Medicine organized by the European Society for Emergency Medicine (EuSEM) in Vienna, Austria, October 1-5.
Matthew Colonnese, Ph.D., assistant professor of pharmacology and physiology at the George Washington University School of Medicine and Health Sciences, was awarded a $1,973,645 grant from the National Eye Institute to study developmental origins of wakefulness in the cerebral cortex, the region of the brain responsible for cognition and perception.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.
Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex Tablets (Pramipexole Dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
› Verified 4 days ago
Tylene Law, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Mr. Derek Eckenrode, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Mrs. Amy Gilbert, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Chelsey Webb, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-258-6833 | |
Deborah Katalenas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Beebe Health Care, Lewes, DE 19958 Phone: 302-645-3300 | |
Mr. Justin Ross Spencer, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3336 Fax: 302-645-0965 |